Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Reddel

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Brain : a Journal of Neurology|February 15, 2015
Expanding the phenotype of GMPPB mutationsMacarena Cabrera-Serrano, Roula Ghaoui, Gianina Ravenscroft, et al.
Annals of Clinical and Translational Neurology|July 29, 2024
The clinical relevance of MOG antibody testing in cerebrospinal fluidMolly Reynolds, Irene Tan, Kristy Nguyen, et al.
Clinical and Experimental Rheumatology|February 28, 2025
Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating ScaleUmesh A Badrising, Robert Henderson, Stephen Reddel, et al.
Brain : a Journal of Neurology|June 23, 2026
Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwideAngela Vincent, Rehab Badi, Nina Barisic, et al.
Computer Methods and Programs in Biomedicine|February 18, 2025
Explainable time-to-progression predictions in multiple sclerosisRobbe D'hondt, Klest Dedja, Sofie Aerts, et al.
The Medical Journal of Australia|February 9, 2025
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2Jessica Shipley, James Beharry, Wei Yeh, et al.
The Medical Journal of Australia|February 9, 2025
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1Jessica Shipley, James Beharry, Wei Yeh, et al.
Journal of Neurology|June 27, 2024
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemicAnoushka P Lal, Yi Chao Foong, Paul G Sanfilippo, et al.
Journal of Neurology|February 3, 2026
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registryAmira Souissi, Francesco Patti, Tim Spelman, et al.
The Lancet. Neurology|September 30, 2022
Diagnosis and classification of optic neuritisAxel Petzold, Clare L Fraser, Mathias Abegg, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Brain : a Journal of Neurology|February 15, 2015
Expanding the phenotype of GMPPB mutationsMacarena Cabrera-Serrano, Roula Ghaoui, Gianina Ravenscroft, et al.
Annals of Clinical and Translational Neurology|July 29, 2024
The clinical relevance of MOG antibody testing in cerebrospinal fluidMolly Reynolds, Irene Tan, Kristy Nguyen, et al.
Clinical and Experimental Rheumatology|February 28, 2025
Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating ScaleUmesh A Badrising, Robert Henderson, Stephen Reddel, et al.
Brain : a Journal of Neurology|June 23, 2026
Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwideAngela Vincent, Rehab Badi, Nina Barisic, et al.
Computer Methods and Programs in Biomedicine|February 18, 2025
Explainable time-to-progression predictions in multiple sclerosisRobbe D'hondt, Klest Dedja, Sofie Aerts, et al.
The Medical Journal of Australia|February 9, 2025
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2Jessica Shipley, James Beharry, Wei Yeh, et al.
The Medical Journal of Australia|February 9, 2025
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1Jessica Shipley, James Beharry, Wei Yeh, et al.
Journal of Neurology|June 27, 2024
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemicAnoushka P Lal, Yi Chao Foong, Paul G Sanfilippo, et al.
Journal of Neurology|February 3, 2026
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registryAmira Souissi, Francesco Patti, Tim Spelman, et al.
The Lancet. Neurology|September 30, 2022
Diagnosis and classification of optic neuritisAxel Petzold, Clare L Fraser, Mathias Abegg, et al.
Pageof 5